aTyr Pharma Announces Third Quarter 2021 Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
aTyr Pharma (LIFE) Tops Q3 EPS by 18c
November 10, 2021 4:47 PM ESTaTyr Pharma (NASDAQ: LIFE) reported Q3 EPS of ($0.42), $0.18 better than the analyst estimate of ($0.60).
Cash, cash equivalents and investments as of September 30, 2021 were $116.4 million.
For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.
... More